Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells. - Wikidata - wikimedia - TriplyDB

Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.

Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.

http://www.wikidata.org/entity/Q39715232

about

Androgen receptor footprint on the way to prostate cancer progression MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans Coactivator MYST1 regulates nuclear factor-κB and androgen receptor functions during proliferation of prostate cancer cells.Andrographolide targets androgen receptor pathway in castration-resistant prostate cancer.MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth Disruption of microtubules sensitizes the DNA damage-induced apoptosis through inhibiting nuclear factor κB (NF-κB) DNA-binding activity Upregulation of glucose metabolism by NF-κB2/p52 mediates enzalutamide resistance in castration-resistant prostate cancer cells.A screen for transcription factor targets of glycogen synthase kinase-3 highlights an inverse correlation of NFκB and androgen receptor signaling in prostate cancer Constitutive activity of the androgen receptor.Minireview: Alternative activation pathways for the androgen receptor in prostate cancer.Function and regulation of Rnd proteins in cortical projection neuron migration Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells.Androgen receptor signaling in prostate cancer development and progression.MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells IκB kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines.Research Resource: Androgen Receptor Activity Is Regulated Through the Mobilization of Cell Surface Receptor Networks.Inhibitor of p52 NF-κB subunit and androgen receptor (AR) interaction reduces growth of human prostate cancer cells by abrogating nuclear translocation of p52 and phosphorylated AR(ser81).Inhibition of constitutive aryl hydrocarbon receptor (AhR) signaling attenuates androgen independent signaling and growth in (C4-2) prostate cancer cells.Lin28 promotes growth of prostate cancer cells and activates the androgen receptor The changing therapeutic landscape of castration-resistant prostate cancer.Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives.NF-κB signaling in prostate cancer: a promising therapeutic target?PPAR gamma, bioactive lipids, and cancer progression.Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer.Maintaining and reprogramming genomic androgen receptor activity in prostate cancer.The role of microRNA in castration-resistant prostate cancer.Correlating phosphoproteomic signaling with castration resistant prostate cancer survival through regression analysis.ZFP91: A Noncanonical NF-κB Signaling Pathway Regulator with Oncogenic Properties Is Overexpressed in Prostate Cancer.Lin28 induces resistance to anti-androgens via promotion of AR splice variant generation.NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer.RhoGDIα downregulates androgen receptor signaling in prostate cancer cells.NF-κB2/p52 induces resistance to enzalutamide in prostate cancer: role of androgen receptor and its variants.Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives.Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.Molecular processes leading to aberrant androgen receptor signaling and castration resistance in prostate cancer.Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells.Inhibition of KPNA4 attenuates prostate cancer metastasis.

P2860

Q26825402-23E9518E-062E-499A-9AE8-F376B4996879 Q27008271-17F0F010-A6EC-455E-933E-0F09A14EFC17 Q33701358-6183038C-71D3-4B63-B2F6-6C42CCF6C0B5 Q33968384-A65C6064-7C08-425B-98C1-6EDC5BD2E0DB Q34221217-B209B548-EDCC-4F71-928E-16D3BA83F6E5 Q34255576-5BCFFAB1-FE87-4A35-9C8E-31CD1D12137D Q34411599-20D7431F-8AE1-48C4-AB36-BA380E384302 Q34483490-0DC11C40-B5E1-4079-8A8A-78DAE1CA1605 Q34775572-88CC4207-F05E-44E4-A375-C33DE0E910AD Q35001285-CD2D4F65-576C-4E84-AF9E-70692EF7B016 Q35056615-CA5746B6-17B0-4C84-8DF2-E8DB088C3C53 Q35109795-6A45E61E-369F-43D0-8308-6843E41614EB Q35183663-C85809E5-28F7-4D0F-8EDA-2FE1E98CAB0F Q35668910-76FECA2E-8C43-40F1-A04D-091882E8940A Q35882191-1E72223D-29D7-49A8-9537-A8174B8FA4AD Q35897569-A64681C6-29C0-4986-BC70-105572518CBC Q36248478-0D245C34-CD5A-48AF-83F5-51FFEC392F82 Q36873039-4262E2CD-839B-4EB6-BC35-FCAAA3E5814B Q36986508-56EF2090-0C99-4474-A3A2-DF8A323FFC63 Q37913983-4D193CC6-8D69-4A59-8CF3-6C33C1DD6727 Q37947091-33AA6BA3-B7A9-4746-B7AE-A8DAEA655A43 Q37956492-71866268-9235-4EE6-8D1C-6397C0D994AE Q37971590-59E9AC0E-BA80-4264-8349-80EADA7C24EB Q38161514-2D4D046A-DB1E-4A7A-BF0F-7BB9138551F8 Q38190362-DF57B647-D4B0-4FB0-B11F-3D638ADE69ED Q38220789-1088991F-F296-439A-AD47-894975A8E123 Q38540474-A842FDA1-095C-4D7D-888B-793F788F68F5 Q38726177-D5B42F03-0ED9-4546-8DC7-8A3E3715AD1A Q38808170-8E87DEC0-B516-41C4-BC72-36C20CC20FB2 Q38865962-1F5B6905-9A4F-4BBB-8F90-E8A26385A40D Q39114221-C3B86C68-714C-49CD-B81D-F02DC9A21D09 Q39148465-034BFC63-29FC-4E5A-84C4-5A2E3C060114 Q39285589-F9FCDA24-6BB8-47CC-ABB5-12D6496A877A Q39340075-113AA0D2-3839-4514-9482-BA96DF33B04E Q39349217-C117F0C1-73B0-4BFA-A885-5695D963C0E3 Q39516408-81D6C578-B302-4CFD-9EED-C2D918F40BEC Q41886996-63EA373F-D6E4-4273-8047-5D83CF37E746 Q46066238-166B3061-E43F-433D-BCA1-B6287BA91810 Q46760444-2DA04ECB-DB55-4E2E-A27E-D6F0531F93DB Q46797418-AE98DF15-E281-43DE-BE16-C40EB6D4DB5A

P2860

Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.

http://www.wikidata.org/entity/Q39715232

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.

@en

Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.

@nl

type

label

Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.

@en

Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.

@nl

prefLabel

Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.

@en

Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.

@nl

P1433

Q39715232-99B0B79C-1CCB-4ADD-B0D7-4016EF7EFCAB

P1476

Q39715232-7EA8C2D1-6683-4C32-96B3-FEFD357E0C0E

P2093

Q39715232-06BACD35-DFA2-49FE-8847-1B66E7FF2065

Q39715232-2FA71234-70CA-4045-AD76-EDBE99D56861

Q39715232-42DDF593-B7D9-4E80-B382-A60FCB6C4344

Q39715232-73669163-2A88-42D3-91DE-19534A01F079

Q39715232-9054BF7E-B3EA-4F5A-818E-BB44C6046906

Q39715232-B65D4B94-FD2A-4BBC-8704-E82F00F08A45

Q39715232-B81DA2C9-6E2C-4ACA-926D-9BC7081CCC75

Q39715232-DB722AFA-18BA-42EF-A4FE-8F778F9B9CBD

Q39715232-F9ED8360-26EE-4516-ABA4-0F7E834E31D4

P2860

Q39715232-063B11F9-E5ED-4B09-9718-B210F2525FCA

Q39715232-0807D479-F629-4FAD-94B9-38E8462E29D3

Q39715232-1E9B1012-3A25-4A6B-B92E-FD095CE5C65A

Q39715232-1FD981EB-10CC-430E-9E37-27F311291270

Q39715232-246A28CC-DD24-4610-A443-09DD70017AEF

Q39715232-2A99CDCC-140B-466A-82A9-8EB9E398D2E3

Q39715232-31B140BF-C714-4886-90EF-A289565E4F37

Q39715232-31CA27AF-A66E-4B3C-AAAD-7EE8D3A95567

Q39715232-39FD28E3-27B0-40AA-A853-89D361BF5CBB

Q39715232-40A47897-49A9-473C-856C-365DE2927192

P304

Q39715232-E14E4491-245D-4DDB-B4DB-F20E8D7DFD82

P31

Q39715232-613F6803-2F20-45FE-A640-6E634F126F22

P356

Q39715232-74B35C98-E5B0-4711-8539-7E2C30D02E19

P407

Q39715232-53A95F94-DF16-4464-99E6-C0E0EEFF507D

P433

Q39715232-85807987-94A4-4FEE-9D41-EBAB2BCBBC4E

P478

Q39715232-818205F0-4C12-4B45-AF6E-1019C8557E8A

P577

Q39715232-438E4C0A-9BD0-4484-B328-09CE2FE4315C

P698

Q39715232-B11CCEB8-DCE2-4B06-AED3-6B88E911152C

P932

Q39715232-E64D1C5B-C2CB-45C8-812E-56D9389BF00F

P356

0008-5472.CAN-09-3703

P1433

Cancer Research

P1476

Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.

@en

P2093

Allen C Gao

http://www.w3.org/2001/XMLSchema#string

Christopher P Evans

http://www.w3.org/2001/XMLSchema#string

Hsing-Jien Kung

http://www.w3.org/2001/XMLSchema#string

Jiao Yue

http://www.w3.org/2001/XMLSchema#string

Jun Chen

http://www.w3.org/2001/XMLSchema#string

Meng Sun

http://www.w3.org/2001/XMLSchema#string

Nagalakshmi Nadiminty

http://www.w3.org/2001/XMLSchema#string

Qinghua Zhou

http://www.w3.org/2001/XMLSchema#string

Wei Lou

http://www.w3.org/2001/XMLSchema#string

P2860

NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100

Stat3 enhances transactivation of steroid hormone receptors

Mutual transcriptional interference between RelA and androgen receptor

CD40 regulates the processing of NF-kappaB2 p100 to p52

Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.

Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer

The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.

Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.

NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer.

Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation.

P304

3309-3319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-09-3703

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20388792

http://www.w3.org/2001/XMLSchema#string

P932

3041633

http://www.w3.org/2001/XMLSchema#string